alexa Are Viral Epitopes Potential Targets for Effective Glioblastoma Immunotherapy

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Are Viral Epitopes Potential Targets for Effective Glioblastoma Immunotherapy

Glioblastoma multiforme (GBM) is an extremely aggressive tumor with a very dismal prognosis. Although extensive efforts have been made to identify new treatment options for these patients to improve their quality of life and survival, the results are not encouraging. The patients are left in a grim situation with a short life expectancy. During the past decade, several groups have demonstrated that human cytomegalovirus (HCMV) nucleic acids and proteins can be detected in GBM tumors, while healthy brain surrounding the tumors remains negative for this virus. While a currently ongoing debate argues for or against the presence of HCMV in GBM, DC vaccinations with GBM tumor lysates have been shown to trigger an HCMV-specific immune response in patients. Moreover, HCMVspecific autologous T cells have proven capable of killing GBM cells. These observations provide immunological evidence that HCMV epitopes exist in these tumors, and support the efforts to utilize HCMV as a target for immunotherapy in GBM patients. Indeed, several HCMV-based immunotherapy trials are ongoing with encouraging results for this group of patients. Furthermore, a retrospective analysis of a cohort of GBM patients who received the anti-HCMV drug Valganciclovir as add-on to standard therapy reveals a potential substantial increase in survival. Thus, we argue that the emerging possibilities to target HCMV to substantially improve the outcome of GBM patients should be given urgent attention. In this review, we discuss potential strategies for medical or immune-based therapies to target HCMV in the context of GBM.

 

 

Citation: 

Wilhelmi V, Stragliotto G, Söderberg-Nauclér C, Landázuri N (2015) Are Viral Epitopes Potential Targets for Effective Glioblastoma Immunotherapy? . J Carcinog Mutagen 6:214.

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords